Department of Vascular Medicine, Academic Medical Centre, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.
BMJ. 2010 Mar 30;340:c1475. doi: 10.1136/bmj.c1475.
In older patients, the the D-dimer test for pulmonary embolism has reduced specificity and is therefore less useful. In this study a new, age dependent cut-off value for the test was devised and its usefulness with older patients assessed.
Retrospective multicentre cohort study.
General and teaching hospitals in Belgium, France, the Netherlands, and Switzerland. Patients 5132 consecutive patients with clinically suspected pulmonary embolism.
Development of a new D-dimer cut-off point in patients aged >50 years in a derivation set (data from two multicentre cohort studies), based on receiver operating characteristics (ROC) curves. This cut-off value was then validated with two independent validation datasets.
The proportion of patients in the validation cohorts with a negative D-dimer test, the proportion in whom pulmonary embolism could be excluded, and the false negative rates.
The new D-dimer cut-off value was defined as (patient's agex10) microg/l in patients aged >50. In 1331 patients in the derivation set with an "unlikely" score from clinical probability assessment, pulmonary embolism could be excluded in 42% with the new cut-off value versus 36% with the old cut-off value (<500 microg/l). In the two validation sets, the increase in the proportion of patients with a D-dimer below the new cut-off value compared with the old value was 5% and 6%. This absolute increase was largest among patients aged >70 years, ranging from 13% to 16% in the three datasets. The failure rates (all ages) were 0.2% (95% CI 0% to 1.0%) in the derivation set and 0.6% (0.3% to 1.3%) and 0.3% (0.1% to 1.1%) in the two validation sets.
The age adjusted D-dimer cut-off point, combined with clinical probability, greatly increased the proportion of older patients in whom pulmonary embolism could be safely excluded.
在老年患者中,D-二聚体检测对肺栓塞的特异性降低,因此不太有用。本研究设计了一种新的、与年龄相关的检测截断值,并评估了其在老年患者中的应用价值。
回顾性多中心队列研究。
比利时、法国、荷兰和瑞士的综合和教学医院。
5132 例连续疑似肺栓塞的患者。
在一个推导集(来自两项多中心队列研究的数据)中,基于接收者操作特征(ROC)曲线为年龄>50 岁的患者设计新的 D-二聚体截断值。然后使用两个独立的验证数据集对该截断值进行验证。
验证队列中阴性 D-二聚体检测患者的比例、能够排除肺栓塞的患者的比例以及假阴性率。
新的 D-二聚体截断值定义为年龄>50 岁的患者中(患者年龄x10)μg/L。在推导集中 1331 例临床可能性评估结果为“不太可能”的患者中,新截断值可排除 42%的肺栓塞患者,而旧截断值(<500μg/L)可排除 36%的患者。在两个验证集中,与旧值相比,新值下 D-二聚体低于截断值的患者比例增加了 5%和 6%。这种绝对值的增加在年龄>70 岁的患者中最大,三个数据集的范围从 13%到 16%。在推导集中失败率(所有年龄)为 0.2%(95%CI 0%至 1.0%),在两个验证集中为 0.6%(0.3%至 1.3%)和 0.3%(0.1%至 1.1%)。
年龄调整的 D-二聚体截断值与临床可能性相结合,大大增加了能够安全排除肺栓塞的老年患者的比例。